Sanjay Bambhaniya · May 19, 2026

Q-Line Biotech SME IPO Details 2026

Q: What is Q-Line Biotech IPO?

The company manufactures and sells medical diagnostic reagents. They also import and distribute pathology devices. They serve hospitals and colleges. The total issue size is ₹214.48 crore. This whole amount comes from a fresh issue of shares. There is no offer for sale. The issue opens on Thu, May 21, 2026. The issue closes on Mon, May 25, 2026. Investors must apply within these dates.

Q: What is the minimum investment for a retail investor?

Retail buyers must apply for a minimum of 2 lots. This equals 800 shares. The total amount required is ₹2,74,400.

Q: On which exchange will the shares list?

The company will list its shares on the NSE SME platform. It is a dedicated segment for smaller firms.

Q: Who are the promoters of Q-Line Biotech Ltd.?

Saurabh Garg and Amita Garg are the main promoters. Ayush Garg and Ajay Kumar Mahanty are also promoters. Abhay Agrawal is a promoter too.

Q: Who is handling the IPO process?

Hem Securities Ltd is the lead manager. Share India Capital Services is the co-manager. Purva Sharegistry is the official registrar.

SME Book Build Listed

Healthcare

NSE SME

Price Band

₹326 - ₹343

Issue Size

₹214.48 Cr

Lot Size

400 shares

Min. Investment

₹1,37,200

Live GMP ₹117

34.11% Est. Listing: ₹460

SIP Calc Compare

IPO Timeline

DRHP FILED —

OPEN May 21, 2026

CLOSE May 25, 2026

ALLOTMENT May 26, 2026

LISTING May 29, 2026

IPO DETAILS REVIEW GMP SUBSCRIPTION ALLOTMENT STATUS

Q-Line Biotech

Company overview & key insights

The Q-Line Biotech IPO size is ₹214.48 crore. This issue includes a fresh issue of ₹214.48 crore. It is a book-building issue. The IPO issue opens on May 21, 2026 and closes on May 25, 2026. The share allotment is expected on May 26, 2026. The listing date is May 29, 2026. Q-Line Biotech Ltd. is based in Lucknow and operates in the Healthcare sector. It filed its DRHP on 30th September 2025. It will list its shares on NSE SME. Purva Sharegistry (India) Pvt.Ltd. is the registrar. Hem Securities Ltd. serves as the merchant banker for the offer.

IPO Highlights

Key details & important dates

IPO Details

Total Issues ₹214.48 Cr

Fresh Issue ₹214.48 Cr

Offer for Sale 0 Cr

IPO Price Band ₹326 - ₹343

Face Value ₹10 per share

Lot Size 400 shares

Listed On NSE SME

IPO Dates

DRHP Filed -

Issue Open May 21, 2026

Issue Close May 25, 2026

Allotment Date May 26, 2026

Refunds Initiation May 27, 2026

Credit of Shares May 27, 2026

Listing Date May 29, 2026

IPO Issue Structure

Reservation & Lot Size Details

The company has reserved shares for various investor categories. The Retail Shares reservation is 35.00% (20,79,200 shares). QIB has 49.99% (29,69,200 shares). Further, the minimum lot size is 400 shares. The anchor investor reservation is 28.48% (17,81,200 shares). The market maker reservation is 5.01% (3,13,200 shares).

IPO Reservation

QIB 29,69,200 (47.48%)

Anchor Investor 17,81,200 (28.48%)

QIB (Ex. Anchor) 11,88,000 (19.00%)

NII (HNI) 8,91,600 (14.26%)

bNII > ₹10L –

sNII < ₹10L –

Retail 20,79,200 (33.25%)

Employee 3,13,200 5.01% (approx. ₹11 Cr)

Shareholder 62,53,200

IPO Lot Size

Retail (Min)

2 | 800 Shares

₹2,74,400

Small Investor Quota

Retail (Max)

2 | 800 Shares

₹2,74,400

Retail Investment Limit

S-HNI (Min)

3 | 1,200 Shares

₹4,11,600

Small HNI (₹2L – ₹10L)

S-HNI (Max)

7 | 2,800 Shares

₹9,60,400

Small HNI (Up to ₹10 L)

B-HNI (Min)

8 | 3,200 Shares

₹10,97,600

Big HNI (Above ₹10L)

Zerodha Apply Now Upstox Apply Now Angel One Apply Now

IPO Documents & GMP

Prospectus & Grey Market Premium

On 30th September 2025 the company filed its Draft Red Herring Prospectus. The Red Herring Prospectus is available to understand the business operations, financials, and the risks involved.

DRHP Document Draft Red Herring Prospectus

RHP Document Red Herring Prospectus

IPO GMP

Live

The Grey Market Premium indicates the extra price that people pay in the unofficial market. This value changes daily based on demand for the shares.

Track live GMP Today

Financial Performance (₹ in Cr)

Period Ended	31-Dec-25	31 Mar 2025	31 Mar 2024	31 Mar 2023
Total Income	232.42	310	313.78	203.64
Profit After Tax	38.69	51.59	28.13	34.44
EBITDA	64.22	85.63	66.21	40.79
Net Worth	229.16	189.94	161.81	127.36
Assets	561.34	455.48	339.24	251.57
Total Debt	243.85	164.94	96.9	73.64

Key Performance Indicator

Particulars	31-Dec-25	FY25	FY24	FY23
EBITDA Margin (%)	27.63	21.1	20.03	19.57
PAT Margin (%)	16.65	8.96	16.91	17.56
EPS (₹)	23.57	28.63	21.87	20.38
ROE (%)	16.88	14.81	21.28	25.2
ROCE (%)	13.32	23.74	21.29	25.2
ROA (%)	6.89	6.18	10.15	12.76
Debt to Equity (x)	1.06	0.87	0.6	0.58

IPO Financial Snapshot

Objectives & Key Metrics

IPO Objectives

Funding working capital requirements of the Company ₹93.50 Cr.

Repayment of certain borrowing availed by the Company ₹90.00 Cr.

General Corporate Purposes ₹0.00 Cr.

Total Fund Requirement ₹183.50 Cr.

IPO Key Metrics

Pre IPO EPS

28.63

Earnings Per Share

Post IPO EPS

–

Earnings Per Share

Pre IPO P/E

–

Price to Earnings

Post IPO P/E

–

Price to Earnings

Market Capitalization ₹204 Cr

Listing Day Trading
NSE SME

Final Issue Price ₹343

Open ₹500.05

Low ₹496.00

High ₹520.85

Last Trade

₹509.65

▲ +48.59%

Check IPO Performance

Quick Links

IPO GMP

Live

Live Subscription Compare Brokers All Brokers

Pro

IPO Calendar Top Performers Upcoming IPOs IPO News List of All Articles…

Calculators

IPO Return

New

SWP Listing Grain View All Calculators →

Q-Line Biotech Ltd. Company Details

Company Profile · Overview

Q-Line Biotech Ltd. started its business in 2010. The company operates in the Healthcare sector. It manufactures reagents for the domestic market. The team provides diagnostic equipment to clients directly or through distributors. Its main office is in Lucknow. The firm employs 126 workers in various departments.

Main Offerings

Indigenous manufacturing of reagents.

Clinical Chemistry kits production.

Haematology and Immunodiagnostics products.

Supply of Pathology equipment.

Key Strengths

Dedicated reverse engineering focus.

Widespread pan-India distribution network.

Strong internal reserve profile.

Experienced senior management team.

Company Address: 289-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012. +91 522-2435570 | compliance@qlinebiotech.com

Intermediaries

Registrar

Purva Sharegistry (India) Pvt.Ltd.

+91-022-23018261 / 23016761

support@purvashare.com

Lead Manager

Share India Capital Services Pvt.Ltd.

Market Maker

Hem Finlease Pvt. Ltd.

RESERVATION 3,13,200 shares (agg. up to ₹11 Cr)

Promoters

Promoter Group

Saurabh Garg Amita Garg Ayush Garg

Frequently Asked Questions

5 FAQs

What is Q-Line Biotech IPO?

The company manufactures and sells medical diagnostic reagents. They also import and distribute pathology devices. They serve hospitals and colleges. The total issue size is ₹214.48 crore. This whole amount comes from a fresh issue of shares. There is no offer for sale. The issue opens on Thu, May 21, 2026. The issue closes on Mon, May 25, 2026. Investors must apply within these dates.

What is the minimum investment for a retail investor?

Retail buyers must apply for a minimum of 2 lots. This equals 800 shares. The total amount required is ₹2,74,400.

On which exchange will the shares list?

The company will list its shares on the NSE SME platform. It is a dedicated segment for smaller firms.

Who are the promoters of Q-Line Biotech Ltd.?

Saurabh Garg and Amita Garg are the main promoters. Ayush Garg and Ajay Kumar Mahanty are also promoters. Abhay Agrawal is a promoter too.

Who is handling the IPO process?

Hem Securities Ltd is the lead manager. Share India Capital Services is the co-manager. Purva Sharegistry is the official registrar.

Sanjay Bambhaniya

Sanjay has 8+ years of experience in data-driven IPO insights. His expertise in digital marketing and web development complements his financial knowledge and helps him to develop effective fintech solutions. He is an entrepreneur and director who helps investors understand complex primary market trends in easy-to-understand IPO reports, news, and updates.

Discussion & Feedback

0 Comments

No comments yet. Be the first to share your thoughts!

Q-Line Biotech SME IPO Details 2026

Q-Line Biotech

IPO Highlights

IPO Details

IPO Dates

IPO Issue Structure

IPO Reservation

IPO Lot Size

IPO Documents & GMP

IPO GMP

Financial Performance (₹ in Cr)

Key Performance Indicator

IPO Financial Snapshot

IPO Objectives

IPO Key Metrics

Listing Day TradingNSE SME

Quick Links

Calculators

Q-Line Biotech Ltd. Company Details

Main Offerings

Key Strengths

Frequently Asked Questions

In the Spotlight

Media Feature

Listing Day Trading
NSE SME